Katia Reda

Katia Reda serves as a Contract Professor at the Department of Law, Economics and Sociology (DiGES) of the Università della Calabria (UniCZ). Her research focuses on innovative cancer therapies, particularly targeting hematologic malignancies and solid tumors through molecular mechanisms involving non-coding RNAs, immunotherapy, and targeted drug delivery systems. She has pioneered studies on bispecific T-cell engagers, G-quadruplex stabilization, and CRISPR-based approaches to identify novel therapeutic targets.

Her work integrates bioinformatics, preclinical models, and clinical trial analysis to advance precision oncology. Key contributions include identifying MALAT1 triplex inhibitors and exploiting the cGAS/STING pathway in immunogenic cell death mechanisms. Katia's interdisciplinary approach bridges molecular biology, pharmacology, and immunology to address challenges in cancer treatment efficacy and resistance.

Notably, her research has explored the role of miR-221/222 in cancer progression and the application of resveratrol in epigenetic modulation. She has also contributed to understanding genetic anomalies in rare cases of SRY-positive females through non-invasive prenatal testing insights.

Despite her affiliation with the DiGES department, her research activities are primarily aligned with medical and life sciences disciplines, reflecting a transdisciplinary academic profile.